Quantum Chemical Investigation, Drug-Likeness and Molecular Docking Studies on Galangin as Alpha-Synuclein Regulator for the Treatment of Parkinson’s Disease
Mohana Priya, Azar Zochedh, Karthick Arumugam, S. Asath Bahadur
Topics & Concepts
GalanginParkinson's diseaseDocking (animal)Alpha-synucleinPharmacologyNeuroscienceMedicineChemistryDiseaseBiologyBiochemistryInternal medicineFlavonoidKaempferolNursingAntioxidantCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsMulticomponent Synthesis of Heterocycles